Cryptosporidiosis is a diarrheal disease caused by microscopic parasites named “Cryptosporidium” that can live in intestine of humans and animals. These parasites are passed through the stool of an infected animal or person.
This report contains market size and forecasts of Cryptosporidium Diagnostic Testing in Global, including the following market information:
Global Cryptosporidium Diagnostic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cryptosporidium Diagnostic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acid-staining Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cryptosporidium Diagnostic Testing include Abbott, BD, Bio-Rad, Danaher, Elitech, American Standard and Grifols, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cryptosporidium Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cryptosporidium Diagnostic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cryptosporidium Diagnostic Testing Market Segment Percentages, by Type, 2021 (%)
Acid-staining Test
Stool Culture
Others
Global Cryptosporidium Diagnostic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cryptosporidium Diagnostic Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Commercial and Private Labs
Physician Offices
Public Health Labs
Global Cryptosporidium Diagnostic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cryptosporidium Diagnostic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cryptosporidium Diagnostic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cryptosporidium Diagnostic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
BD
Bio-Rad
Danaher
Elitech
American Standard
Grifols